Pelamed Pharmaceuticals had EBIT of $266 million in 2018, interest expenses of $71 million, and a corporate tax rate of 35%.

a. What wasPelamed's 2018 netincome?

b. What was the total ofPelamed's 2018 net income and interestpayments?

c. If Pelamed had no interestexpenses, what would its 2018 net income havebeen? How does it compare to your answer in parta?

d. What was the amount ofPelamed's interest tax shield in 2018?